VV116 or Nirmatrelvir-Ritonavir for Oral Treatment of Covid-19.
Dan-Yu Lin, Thomas R Fleming
Author Information
- Dan-Yu Lin: University of North Carolina at Chapel Hill, Chapel Hill, NC lin@bios.unc.edu.
- Thomas R Fleming: University of Washington, Seattle, WA.
No abstract text available.
- R01 HL149683/NHLBI NIH HHS
- R37 AI029168/NIAID NIH HHS
Humans
Ritonavir
COVID-19
COVID-19 Drug Treatment
nirmatrelvir
Ritonavir
GS-621763
